OncoTEX is developing TEX Core, a world-first oncology drug platform designed to create innovative therapies capable of overcoming multiple limitations often associated with current cancer therapeutics, including the predominant platinum-based resistance. OxaliTEX is the first clinical candidate developed from the TEX Core platform for the treatment of platinum-resistant ovarian cancer. TEX Core is designed to target tumor cells by overcoming challenges associated with the current platinum-based standards-of-care (SOC).
Company Details
- Employees
- 4
- Address
- 3800 N Lamar Blvd, Austin,texas 78756,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- columbusccop.org
- Keywords
- Hospitals and Health Care.
- HQ
- Austin, Texas
Oncotex Questions
Oncotex's website is columbusccop.org
Oncotex's LinkedIn profile is https://www.linkedin.com/company/oncotex-inc
Oncotex has
4 employees.
View email and phone details for 4
employees at Oncotex.
Oncotex's industry is
Biotechnology Research
Oncotex's categories are Biotechnology Research
